Catalyst Wire Dossier Catalyst Wire Dossier

Lactobacillus reuteri Prodentis

Lactobacillus reuteri
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lactobacillus reuteri Prodentis, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Microbiological Effect of 0.12% Chlorhexidine Digluconate and 0.05% Cetylpyridinium Chloride vs Probiotics (Lactobacillus Reuteri Prodentis) on Porphyromonas Gingivalis. [Phase 4]

See pricing